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Oxygen-sensitive
3He-MRI in bronchiolitis
obliterans after lung transplantation
Abstract Oxygen-sensitive
3He-MRI
was studied for the detection of
differences in intrapulmonary oxygen
partial pressure (pO2) between
patients with normal lung transplants
and those with bronchiolitis obliterans
syndrome (BOS). Using software de-
veloped in-house, oxygen-sensitive
3He-MRI datasets from patients with
normal lung grafts (n=8) and with
BOS (n=6) were evaluated quantita-
tively. Datasets were acqiured on a
1.5-T system using a spoiled gradient
echo pulse sequence. Underlying dis-
eases were pulmonary emphysema
(n=10 datasets) and fibrosis (n=4).
BOS status was verified by pulmonary
function tests. Additionally,
3He-MRI
was assessed blindedly for ventilation
defects. Median intrapulmonary pO2
in patients with normal lung grafts was
146 mbar compared with 108 mbar in
patients with BOS. Homogeneity of
pO2 distribution was greater in normal
grafts (standard deviation pO2 34
versus 43 mbar). Median oxygen
decrease rate during breath hold was
higher in unaffected patients
(−1.75 mbar/s versus −0.38 mbar/s).
Normal grafts showed fewer ventila-
tion defects (5% versus 28%, med-
ians). Oxygen-sensitive
3He-MRI
appears capable of demonstrating dif-
ferences of intrapulmonary pO2
between normal lung grafts and grafts
affected by BOS. Oxygen-sensitive
3He-MRI may add helpful regional
information to other diagnostic tech-
niques for the assessment and follow-
up of lung transplant recipients.
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3He-MRI is a novel technique for functional imaging of
the lung. A variety of different pulse sequence types have
been described, including spin density, diffusion-weighted,
dynamic ventilation and oxygen-sensitive imaging [1–4].
Spin density and dynamic imaging have been applied to
lung transplant recipients with the aim to improve non-
invasive image-based diagnostics of obliterative bronchi-
olitis (OB) [5, 6]. In a follow-up study, spin density
imaging detected OB earlier than pulmonary function tests
in two out of five cases [7].
Pulmonary function testing (PFT) is widely used as the
standard diagnostic tool for the follow-up of lung trans-
plant recipients. Transbronchial lung biopsies can confirm
clinical suspicion of bronchiolitis obliterans syndrome
(BOS). Both approaches have inherent disadvantages. PFT
remains a global screen in which functional impairment of
lung regions affected by OB may be compensated for by
healthy regions [8]. Bronchoscopy with transbronchial
biopsy is invasive. Due to the inhomogeneous distribution
of OB, foci of disease can be missed [9]. Computed
tomography (CT), the standard imaging method in lung
transplant recipients, is only moderately sensitive in the
detection of OB [10].
3He-MRI is a sensitive method to detect ventilatory
disturbances in a variety of lung diseases [11–14]. Patients
with a clinical diagnosis of BOS show an increased
incidence of ventilation defects when compared with
patients with a normal lung graft [7]. Since in OB ven-
tilation becomes impaired by obliteration of small airways,
impaired pulmonary gas exchange may reduce local
alveolar oxygen partial pressure (pO2) even before a lung
region shows signal loss due to attenuated
3He intake.
Oxygen-sensitive
3He-MRI has been validated as a non-
invasive method to measure the regional distribution of
intrapulmonary pO2 [15, 16].
In oxygen-sensitive
3He-MRI the T1-shortening effect
of molecular oxygen is used to calculate the pO2 in a
respective volume of interest by signal intensity changes in
repeated imaging during a single breath-hold. Intrapulmo-
nary pO2 is the result of a local steady-state balance
between alveolar ventilation and perfusion of the pulmo-
nary capillary bed, i.e. a regional V
0
A=Q ratio. Since BO is
an airway disease, ventilation becomes impaired in affected
regions of the lung. Perfusion will adapt to these changes
depending on the responsiveness of hypoxic pulmonary
vasoconstriction. In a state of local alveolar hypoventila-
tion, the resultant decrease of intrapulmonary pO2 is
expected to be compensated for, at least partially, by
adaptive changes in perfusion. Nevertheless, the distribu-
tion of V
0
A=Q ratios and hence, intrapulmonary pO2 values,
would be expected to widen. Even more so, since BO itself
is distributed rather inhomogeneously.
The present study investigates whether 3He-MRI is
capable of differentiating BOS from normal lung grafts,
based on the measurements of the intrapulmonary pO2
measured by oxygen-sensitive
3He-MRI. This might help
to better delineate the role of functional
3He-MRI in the
early detection of OB.
Materials and methods
Patients
Approval of the University’s Ethics Committee and written
informed patient consent were obtained for follow-up after
lung transplantation including functional
3He-MRI.
The cohort of this retrospective evaluation consisted of
12 patients (three female, nine male) aged between 39 and
61 years (median, 51). There were four double-lung
recipients and eight single-lung recipients. The underlying
disease necessitating lung transplantation was terminal
emphysema in eight cases (including two cases with α-1-
antitrypsin deficiency) andidiopathic pulmonary fibrosis in
the remaining four (including two with acute interstitial
pneumonia). Two of these patients contributed two datasets
during follow-up, so a total of 14 datasets from these 12
patients were used for postprocessing. Of these datasets,
eight were acquired in normal grafts, and six in presence of
a clinical diagnosis of BOS. The cohort was selected from a
group of 23 consecutively scanned lung transplant
recipients during a period of 26 months.
Conventional follow-up and diagnosis of BOS were
performed according to current recommendations of the
International Society for Heart and Lung Transplantation,
including serial pulmonary function testing (PFT) [17].
BOS was diagnosed on grounds of PFT deterioration if the
ratio between current forced expiratory volume in 1 s
(FEV1) and the best post-operative FEV1 became smaller
than 0.81.
Inclusion criterion for this observational series was an
oxygen-sensitive MRI dataset of diagnostic quality. Image
series with low signal-to-noise ratio (SNR≤3) due to low
gas intake, very advanced states of BOS and prematurely
aborted breath-holding were excluded from the study.
3He-Gas
Polarization, storage, transport and application of
3He
have been described in detail elsewhere [18, 19]. We used
3He polarized to 40–45% by metastability exchange optical
pumping. The
3He gas was administered to the patients
using a computer-controlled application device. The device
was connected to an intensive care-type ventilator (Servo
531900 C, Siemens Medical Solutions, Erlangen, Germany)
and operating in the pressure-support mode, in order to
allow a comfortable spontaneous breathing pattern. For
imaging approximately 300 ml of hyperpolarized
3He were
administered within a single breath to the patient.
Imaging
All measurements were performed on a 1.5-Tclinical scanner
(Magnetom Vision, Siemens Medical Solutions, Erlangen,
Germany) tuned to the Larmor frequency of
3He (48.5 MHz).
The scanner was equipped with a broadband amplifier and a
dedicatedcertifieddoubleresonant(
1Hand
3He)birdcagecoil
(Fraunhofer Institut, St. Ingbert, Germany) for transmission
and reception of radio frequency pulses. We used a spoiled
gradient echo pulse sequence oriented coronally with the
followingparameters:repetitiontime11ms,echotime4.2ms,
flip angle <10°. Omission of a slice selection gradient lead to
“single slice” projection images. In plane resolution was
3.95×2.5 mm at an acquisition matrix of 81×128 and a field
of view of 320 mm. A double-acquisition technique allowed
for mathematical separation of the effects of radio frequency
pulses and T1 relaxation of
3He due to the presence of
molecular oxygen. This included two imaging series,
consisting of eight images, with each series acquired during
inspiratory breath hold. In both series, all parameters had to be
keptconstant(includinginspiredgasand
3Hevolumes)except
the inter-scan interval. This parameter was set to 1.005 s in the
first, and 3, 4, or 5 s in the second imaging series, the latter
depending on the patients’capability to hold their breath [15].
Duringthesameimagingsession,
3Hespindensityimages
were acquired using the same scanner and coil. This was
doneduringinspiratorybreath-holdusingatwo-dimensional
spoiled gradient echo pulse sequence. Images were oriented
coronally and provided a slice thickness of 10–15 mm with
Fig. 2 Distribution of standard deviations of intrapulmonary pO2
(box-whisker plot). Standard deviation is larger in patients suffering
from BOS, reflecting a greater inhomogeneity of intra-pulmonary
pO2 distribution in this disease [plot depicting median, 25th and
75th percentiles (box), and minimum and maximum values
(whiskers) of intra-individual pO2 standard deviations]
Fig. 1 Intrapulmonary pO2 levels in BOS affected and normal lung
grafts [plot depicting median, 25th and 75th percentiles (box), and
minimum and maximum values (whiskers)]. There is a clear
tendency for lower pO2 values in the BOS group
Fig. 3 Decrease rate (RO2) of intrapulmonary pO2 during breath-
hold (box-whisker plot). A smaller RO2 is an indirect indicator that
oxygen uptake is lower in BOS when compared with normal lung
grafts [plot depicting median, 25th and 75th percentiles (box), and
minimum and maximum values (whiskers)]
Table 1 Tabulated results of all evaluated datasets, including
ventilation defect percentage (SDpO2 standard deviation of oxygen
partial pressure)
Dataset BOS pO2 (mbar) SDpO2 (mbar) Ventilation defect (%)
1 + 106 57 10
2 + 131 40 30
3 + 129 54 35
4 + 110 17 87.5
5 + 79 45 25
6 + 86 42 10
7 – 143 31 7.5
8 – 121 17 5
9 – 155 23 4
10 – 141 37 10
11 – 167 60 5
12 – 149 26 15
13 – 108 39 4
14 – 179 38 5
532aninterslicegapof2–5mm(repetitiontime11ms,echotime
4.2 ms, flip angle10°, centricreordering,in-plane resolution
4.2×2.7 mm, matrix 81×128, field of view 340 mm, sinc
interpolation to a 256 matrix).
Image evaluation
Images were transferred to a commercially available IBM-
compatible PC. An in-house developed software based on
PV-Wave (Visual Numerics, Boulder, Colo.) was used for
post-processing [20,21]. Thesoftware is able to read image
files in the DICOM standard and automatically excludes
regions with a SNR of 3.0 or less. Filtering in the image
domain reduced remaining noise. The software calculates
the intrapulmonary pO2 following the physical relationship
between noise-corrected signal intensity (A) decay in two
series of n images each, taken at different interscan delays
τ1 and τ2, and pO2:
1nA n;τ1=A0 ðÞ   1nA n;τ2=A0 ðÞ ¼ fp O 2 ðÞ :
Results are displayed in colour-coded maps. In order to
account for remaining image noise, a 2×2 matrix of image
pixels was averaged giving the final 64×64 matrix, to be
analysed for pO2. The resultant in-plane resolution was 5×
5 mm. The software calculates mean pO2 and its standard
deviation as well as the pO2 decrease rate during the period
of apnea while the imaging process takes place (RO2). In
case of unilateral lung transplants only the grafts underwent
evaluation.
Spin density images were assessed for ventilation
defects by two observers with several years practice in
interpreting
3He-images. They were blinded to patient
history except for transplant status (single, right, left,
double). The total volume of ventilation defects was
estimated as percentage of total lung volume and expressed
as means of both observers’ results.
Statistical analysis
Data analysis was limited to descriptive statistics and
graphic displays using box-whisker plots; significance
testing, as well as the calculation of an interobserver
agreement in the assessment of ventilation defects, was
omitted due to the small study sample. Descriptive
comparisons were made of mean intrapulmonary pO2,
intraindividual pO2 standard deviation in order to describe
Table 2 Tabulated results for the
assumption of a non-
Gaussian (median, inter-quartile
range, range) and a Gaussian
(mean, standard deviation, con-
fidence interval) distribution
(IQR interquartile range, SD
standard deviation, CI confidence
interval at α=0.050)
BOS Normal
pO2 (mbar) Median 108 146
IQR 33 21
Range 52 71
Mean 107 146
SD 34 13
CI 27 9
SDpO2 (mbar) Median 43 34
IQR 13 13
Range 40 43
Mean 42 34
SD 13 13
CI 10 9
RO2 (mbar) Median −0.38 −1.75
IQR 1.24 1.08
Range 9.69 2.34
Mean 0.24 −1.99
SD 3.05 0.83
CI 2.4 0.55
Ventilation defect (%) Median 28 5
IQR 20 3
Range 78 11
Mean 33 7
SD 29 4
CI 23 3
533homogeneity of its distribution and for mean decrease rate
of pO2 during apnea.
A systematic error towards lower pO2 in image sets with
poor SNR, which could be due to the influence of noise on
the post-processing results, was studied by regression
analysis of SNR and pO2 data.
Results
Median intrapulmonary pO2 in grafts of patients with
diagnosed BOS was 108 mbar (range, min 79 mbar, max
131 mbar, see also Table 1), compared with an intrapul-
monary pO2 of 146 mbar (median; range, min 108 mbar,
Fig. 4 a Intrapulmonary pO2-map of a patient with a normal lung
graft of a 42-year-old female after right-sided lung transplantation
for terminal emphysema. b Ap O 2 map of the same patient after
development of BOS, with a decline of FEV1 of 30% of her best
post-operative FEV1. c pO2 histogram of the same patient at normal
graft function, and d after development of BOS. The diminished and
more inhomogeneous intrapulmonary pO2 after BOS development
can be well appreciated in the colour-coded maps as well as in the
respective pO2 histograms
534max 179 mbar) in normal grafts. There was an overall trend
towards lower intrapulmonary pO2 levels in BOS patients
shown by Fig. 1. In BOS patients, intrapulmonary pO2 had
a wider distribution, indicating a greater degree of venti-
lation-perfusion inhomogeneity (Fig. 2). Median standard
deviation was 43 mbar in BOS patients versus 34 mbar in
those with normal lung grafts. RO2, i.e. pO2 decrease rate
during breath-holding, was less steep in BOS patients
(median, −0.38 mbar/s breath-hold) than in unaffected
patients (median, −1.75 mbar/s breathhold) (Fig. 3). As the
number of study participants is low, Table 2 lists results for
assumptions of Gaussian and non-Gaussian distribution.
Colour-coded maps showed a normal mean intrapulmo-
nary pO2 level with a quite homogeneous distribution in
normal lung grafts, but lower and inhomogeneously
distributed pO2 levels in patients suffering from BOS
(Fig. 4). Accordingly, ventilation defects were smaller in
normal grafts. Patients with normal grafts presented with a
median ventilation deficit of 5% (min 4%, max 15%)
versus BOS patients with 28% (min 10%, max 88%).
Regression analysis did not detect any systematic linear
relationship between SNR data and pO2 measurements
(r=0.21, Fig. 5). A systematic error towards lower pO2 in
lung images displaying poor SNR, like those affected by
BOS, was therefore not substantiated.
Discussion
In 12 recipients of unilateral or bilateral lung transplants,
oxygen-sensitive
3He-MRI was added to post-transplant
follow-up studies. In a total of 14 datasets, those from
patients with normal lung grafts were compared with those
from patients diagnosed with BOS. Analysis of intrapul-
monary pO2 data of the grafts demonstrated overall lower
and more inhomogeneously distributed intrapulmonary
pO2 in patients diagnosed with BOS when compared with
patients with an unaffected graft.
As a first step toward the goal of earlier non-invasive
diagnosis of BOS, the technique and findings of this study
confirm the predicted reduction of mean intrapulmonary
pO2 and greater inhomogeneity of its distribution in
clinically manifest BOS. The study showed that the pO2
decrease rate during apnea (RO2) was smaller in BOS
grafts than in clinically unaffected transplants. Patients not
affected by BOS showed results similar to those deter-
mined in healthy volunteer subjects (mean±SD, 153±
11 mbar) reflecting a normal ventilation and oxygen
exchange [22].
A major limitation of the technique is demonstrated in
the pO2 maps of Fig. 4. One of the intrinsic disadvantages
is that oxygen sensitive
3He-MRI is critically dependent on
alveolar entry of sufficient amounts of hyperpolarized
3He
gas. When a lung area contains no signal due to hypoven-
tilation, no pO2 can be determined. However, such areas
are easily delineated in spin density MR images of the lung
as ventilation defects. It has been demonstrated in previous
studies that patients affected by BOS show more and larger
ventilation defects than non-affected patients [7, 23].
There is a variety of other conditions that may cause
reduction and inhomogeneity of intrapulmonary pO2 dis-
tribution. Such abnormalities are known to occur in acute
pulmonary embolism [24–27], in chronic thromboembolic
pulmonaryhypertension,aswellasinpulmonaryfibrosisor
emphysema [1, 28, 29].
Ap O 2 analysis based on images with low SNR may
theoretically introduce a systematical measurement error
because of the magnitude reconstruction of the MR images
[30]. To study the relevance of this bias, image SNR and
resultant pO2 were correlated. We found a nonsignificant
correlation with a coefficient r=0.21, which does not
definitively exclude SNR dependency of the pO2 measure-
ments, but indicates at least minor importance.
Thereareseverallimitationstothepresentstudy.First,the
small and relatively inhomogeneous study sample, with
incompleteindependenceofcomparedgroups,allowsonlya
rather conservative interpretation of the results, and calls for
further confirmation in larger cohorts. Technically, the pulse
sequenceappliedforpO2measurementisatwo-dimensional
sequence without slice selectivity. Such projection images
are robust against diffusion of
3He polarization out of, or
into, an imaged slice during the measurement interval, but
they are inherently of restricted spatial resolution. First
steps have been taken to develop and validate three-
dimensional imagimg sequences, which provide marked
spatial resolution and are, at the same time, robust against
moleculardiffusioneffects[31,32].Finally,SNRremainsa
pivotal issue in oxygen-sensitive
3He MRI. The gas used in
the present study was polarized to a grade of 40–45%.
Meanwhile, new gas polarizers have been developed which
achieve polarization grades of up to 60%. Higher polariza-
tion is expected to improve accuracy of
3He-MRI based
pO2 measurements as the error produced by image noise is
decreased.
Fig. 5 Correlation between intrapulmonary pO2 and SNR for all
datasets. The low correlation coefficient reflects that lower pO2
measurements in BOS grafts compared with normal lung grafts are
very probably not due to a systematical error in pO2 calculation
routines related to poor SNR
535Currently, a non-invasive, sensitive and specific method
to detect BO in lung transplant recipients is lacking [8–10].
Nevertheless, early detection of the disease is crucial for
timely adaptation of the immunosuppressant regimen, in
order to preserve as much graft function as possible [33–
35]. Although
3He-MRI may not prove to offer sufficient
sensitivity and specificity to serve as a single diagnostic
tool for BO detection, it may become of diagnostic use
when combined with other imaging methods [36], e.g. to
exclude infectious causes for deterioration of respiratory
function [37]. Also, the regional information derived from
3He-MRI may provide a road map for transbronchial
biopsies, in order to target the most severely affected areas
at the least possible discomfort for the patient.
Conclusion
Oxygen sensitive
3He-MRI appears capable to differentiate
pO2 level grades, distribution and uptake between normal
lung grafts and those affected by BOS in lung transplant
recipients. Intrapulmonary pO2 determined by oxygen
sensitive
3He-MRI, and its spatial and temporal distribution
analysis might become a valuable supplement to current
methods for the assessment and follow-up of lung trans-
plant recipients.
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